BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23981375)

  • 1. Tanshinone I protects mice from aristolochic acid I-induced kidney injury by induction of CYP1A.
    Feng C; Xie X; Wu M; Li C; Gao M; Liu M; Qi X; Ren J
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):850-7. PubMed ID: 23981375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baicalin Protects Mice from Aristolochic Acid I-Induced Kidney Injury by Induction of CYP1A through the Aromatic Hydrocarbon Receptor.
    Wang K; Feng C; Li C; Yao J; Xie X; Gong L; Luan Y; Xing G; Zhu X; Qi X; Ren J
    Int J Mol Sci; 2015 Jul; 16(7):16454-68. PubMed ID: 26204831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Naphthoflavone protects mice from aristolochic acid-I-induced acute kidney injury in a CYP1A dependent mechanism.
    Xiao Y; Xue X; Wu YF; Xin GZ; Qian Y; Xie TP; Gong LK; Ren J
    Acta Pharmacol Sin; 2009 Nov; 30(11):1559-65. PubMed ID: 19890363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury.
    Xue X; Xiao Y; Zhu H; Wang H; Liu Y; Xie T; Ren J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3074-81. PubMed ID: 18495746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model.
    Levová K; Moserová M; Kotrbová V; Sulc M; Henderson CJ; Wolf CR; Phillips DH; Frei E; Schmeiser HH; Mares J; Arlt VM; Stiborová M
    Toxicol Sci; 2011 May; 121(1):43-56. PubMed ID: 21362632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
    Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
    Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.
    Stiborová M; Levová K; Bárta F; Shi Z; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Arlt VM
    Toxicol Sci; 2012 Feb; 125(2):345-58. PubMed ID: 22086975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I.
    Levova K; Moserova M; Nebert DW; Phillips DH; Frei E; Schmeiser HH; Arlt VM; Stiborova M
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):360-7. PubMed ID: 22982977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockout and humanized mice as suitable tools to identify enzymes metabolizing the human carcinogen aristolochic acid.
    Stiborová M; Frei E; Arlt VM; Schmeiser HH
    Xenobiotica; 2014 Jan; 44(2):135-45. PubMed ID: 24152141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo.
    Dračínská H; Bárta F; Levová K; Hudecová A; Moserová M; Schmeiser HH; Kopka K; Frei E; Arlt VM; Stiborová M
    Toxicology; 2016 Feb; 344-346():7-18. PubMed ID: 26845733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytochromes P450 1A1 and 1A2 participate in detoxication of carcinogenic aristolochic acid.
    Sistkova J; Hudecek J; Hodek P; Frei E; Schmeiser HH; Stiborova M
    Neuro Endocrinol Lett; 2008 Oct; 29(5):733-7. PubMed ID: 18987598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
    Stiborova M; Frei E; Arlt VM; Schmeiser HH
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
    Jerabek P; Martinek V; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats.
    Stiborová M; Levová K; Bárta F; Šulc M; Frei E; Arlt VM; Schmeiser HH
    Mutagenesis; 2014 May; 29(3):189-200. PubMed ID: 24598128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse.
    Rosenquist TA; Einolf HJ; Dickman KG; Wang L; Smith A; Grollman AP
    Drug Metab Dispos; 2010 May; 38(5):761-8. PubMed ID: 20164109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity.
    Chen M; Gong L; Qi X; Xing G; Luan Y; Wu Y; Xiao Y; Yao J; Li Y; Xue X; Pan G; Ren J
    Toxicol Sci; 2011 Aug; 122(2):288-96. PubMed ID: 21613233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I.
    Xue X; Gong LK; Maeda K; Luan Y; Qi XM; Sugiyama Y; Ren J
    Mol Pharm; 2011 Dec; 8(6):2183-92. PubMed ID: 21980933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen.
    Stiborová M; Sopko B; Hodek P; Frei E; Schmeiser HH; Hudecek J
    Cancer Lett; 2005 Nov; 229(2):193-204. PubMed ID: 16125300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity.
    Xiao Y; Ge M; Xue X; Wang C; Wang H; Wu X; Li L; Liu L; Qi X; Zhang Y; Li Y; Luo H; Xie T; Gu J; Ren J
    Kidney Int; 2008 Jun; 73(11):1231-9. PubMed ID: 18368031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.